intracerebral hemorrhage is increased in ESRD patients. Hemodialysis patients are at greater risk of bleeding because of anticoagulant therapy (e.g., heparin and low molecular weight heparins), defective platelet adhesion, anemia and inadequate control of hypertension. A hemorrhage may be intraparenchymal, subdural, epidural, or subarachnoid.
Posterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndrome's clinical presentation includes seizures, severe headaches, and mental and visual changes. The characteristic neuroradiological lesions are located in the posterior (i.e., parietooccipital lobes) white matter and may involve the overlying gray matter. Hypertensive encephalopathy is a neurological syndrome that presents the same symptoms and imaging findings as the other causes of PRES. Sudden increases in blood pressure and subsequent renal failure are the most frequent etiologies described in the literature (7) . In addition, immune suppression using cyclosporine-A and tacrolimus, eclampsia, and the use of various cytotoxic agents may also cause PRES. An acute hypertensive attack was the primary trigger for PRES in most of the cohort studies conducted. When an acute increase in blood pressure exceeds the autoregulatory capacity of the central nervous system (CNS) vessels, regions of vasoconstriction and vasodilatation develop, typically at the arterial boundary zones. This is followed by a breach of the bloodbrain barrier, causing a transudation of fluid and a petechial hemorrhage (7) . Notably, some of the cases studied were normotensive (8) . The uremic milieu of ESRD has also been proposed as an independent triggering agent (9) .
The posterior brain involvement can be explained by the weaker auto-regulatory mechanisms in the posterior cerebral vasculature due to relatively few sympathetic innervations (7, 10) . The clinical and neuroradiological reversibility of this syndrome is well known, but recurrence of PRES is very rare (11) . If the initial trigger redevelops, the same vasogenic response is likely to be generated in the CNS vasculature.
On MR images, the bilateral symmetrical edema in the parietooccipital region, supplied by the posterior cerebral circulation, is hyperintense on T2-weighted and FLAIR sequences and hypointense on T1-weighted sequences (Fig. 2) . The calcarine fissure and paramedian lobe are generally not affected. The high signal intensity in
Intracerebral hemorrhage
There is a high incidence of intracerebral hemorrhage in hemodialysis patients (4, 6) . In the general population, the underlying cause of intracerebral hemorrhage is atherosclerosis, the same underlying cause of SCI. ESRD patients bear an increased risk of atherosclerosis. Hence, the incidence of both SCI and the ADC maps is high in PRES. The signal intensity of the lesion is normal or decreased in DW MR images. The vasogenic edema of PRES (i.e., low signal on DW MR images) is differentiated from cytotoxic edema, which indicates an acute cerebral infarct (i.e., high signal in the DW images).
Osmotic demyelination syndrome
Osmotic demyelination syndrome is a clinicopathological entity that results in convulsions and a change in consciousness and is characterized by pontine and extrapontine region edema and demyelination. The processes that cause the edema and demyelination are unknown. However, a rapid correction of chronic hyponatremia, which is a change in abnormal blood gases also referred to as "fluid-electrolyte imbalances", is known to frequently cause ODS. In addition, direct osmotic changes and the uremia-related accumulation of metabolites in hemodialysis patients may cause a sudden fluid transfer from the extracellular brain areas into the brain cells (i.e., edema) and demyelination, resulting in ODS (12) . This uremia-related accumulation of metabolites is the most important mechanism in the development of ODS in ESRD patients.
Cranial MRI findings, both in the general population and in ESRD patients, have revealed primarily symmetric pontine lesions with increased signals on T2-weighted, proton density-weighted, or FLAIR images (Fig. 3) . In addition, lesions may also involve the pontine and/or extrapontine areas, basal ganglia, bilateral thalamus, cerebral peduncles, and corticomedullary junction of the cerebrum and spinal cord. The involvement of the cerebellar peduncles has been reported in a few rare cases (13) .
Cerebral infections
Uremic patients have both humoral and cellular immune deficiencies. Lymphocytopenia and lymphocyte function disturbances are also often encountered in cerebral infections. Both T and B cells are affected, as well as nonspecific cells (i.e., granulocytes and phagocytes). In addition to a decrease in chemotaxis and an insufficient inflammatory response, the cellmediated (i.e., delayed-type) hypersensitivity response is deficient (14) . Iron overload, elevated levels of intracellular calcium, and hemodialysis treatment are known to contribute to the development of an infection. The uremic toxins that accumulate in the blood serum of uremic patients also inhibit the nonspecific immune system. ESRD patients are more susceptible to infections, but it is not clear why viral infections are less frequently encountered than fungal and bacterial causes (Fig. 4) (14) .
Persistence of gadolinium in the cerebrospinal fluid
The persistence of gadolinium in the cerebrospinal fluid (CSF) is the cause of an increased signal intensity in the subarachnoid space, observed in the T1-weighted and FLAIR MR images following intravenous gadolinium administration (Fig. 5) . This may lead to diagnostic confusion, predominantly of pathologies causing a protein increase in the CSF (e.g., infection, hemorrhage, and neoplasia) and of cases of renal failure in which renal elimination of gadolinium is prolonged, and gadolinium is thus excreted into the CSF. The abnormal increase in the plasma concentration of gadolinium, distributed into all of the extracellular body compartments, causes gadolinium to diffuse through the permeable and semi-permeable membranes. The tight junctions of the endothelium in the cerebral capillaries form a selectively permeable structure. The cerebral choroid plexus and the ocular ciliary body contain fenestrated capillary endothelium. This fenestration may be one possible site for diffusion of the contrast agent. The circumventricular structures are other sites where gado- linium may move along an osmotic gradient, prolonging the elevation of the plasma concentration (15) . Gadolinium accumulation in the subarachnoid space is a potentially under-recognized phenomenon and may cause some confusion in diagnosis. Thus, accumulation should be differentiated from other possible causes, such as bleeding, infections, and complications from electrolyte alterations in ESRD patients. This knowledge would likely prevent diagnostic errors and unnecessary interventions (16).
Sinus vein thrombosis
ESRD patients also have predisposing factors that lead to sinus vein thrombosis. Cerebral venous sinus thrombosis is a rare but potentially dangerous disease. Clinical presentations involve different parts of the cerebral venous system. Initial symptoms include a headache of varying severity, raised intracranial pressure, and cerebral venous infarcts, which are frequently hemorrhagic and may lead to seizures, neurologic deficits, disorders of consciousness, or death.
A computed tomography (CT) scan is usually the first diagnostic assessment performed in an emergency situation. Although a CT scan can detect a spontaneously hyperdense thrombosed sinus at times, it usually shows nonspecific changes, such as hypodensities, blood, and contrast enhancement; in up to 30% of cases, the CT scan findings are normal. The present "gold standard"
for the diagnosis of SVT is no longer cerebral angiography but MRI, which displays the thrombosed sinus as an increased signal on both T1-and T2-weighted imaging (Fig. 6 ). The signal characteristics will vary depending on b a the time at which the MRI was performed in relation to the onset of the thrombosis. A MR venography is, nevertheless, indicated in the very early (i.e., before day 5) or late (i.e., after 6 weeks) stages when a false-negative result from MRI may occur or whenever a routine MRI shows equivocal signs. Although MRIs and MR venograms are now the preferred imaging methods, a conventional angiogram may be necessary for patients with cortical vein involvement or equivocal MRI studies (17) .
Dialysis disequilibrium syndrome
Dialysis disequilibrium syndrome is an acute neurological disorder that occurs in patients receiving hemodialysis. Clinical features include headache, nausea, blurry vision, hypertension, seizures, and coma (18) . It is most often seen in patients undergoing rapid hemodialysis during one of the initial treatments. The diagnosis is one of exclusion; uremia, hyponatremia, hypoglycemia, stroke, and subdural hematoma must be excluded first. While there is no definitive diagnostic test, many authors agree that the clinical presentation is the result of cerebral edema, a direct result of dialysis treatment. The pathophysiology and description of this edema have been controversial (18) . Increased levels of cerebral edema, particularly in the posterior parietooccipital regions, have even been documented by MRI in patients on hemodialysis who have no neurological symptoms (19) .
In conclusion, acute cerebrovascular events, which are the most frequent cause of morbidity and mortality in ESRD patients, have various clinical manifestations. In ESRD patients, MRI is a valuable assessment method that aids in the early diagnosis of acute cerebrovascular events.
